Kearns–Sayre syndrome and large-scale mitochondrial DNA deletion disorders
The Ukrainian Biochemical Journal · 05.11.2026 · 98 (5) · 5-16
DOI: 10.15407/ubj98.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 05.11.2026. Verfasst von R. Syrvatka und 4 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben.
Abstract (Originalsprache)
Background
Mitochondrial diseases are a group of rare disorders caused by alterations in mitochondrial DNA (mtDNA). Kearns–Sayre syndrome is characterized by a large-scale mtDNA deletion that impairs the synthesis of respiratory chain components, leading to cellular energy depletion and oxidative stress.
Objective
To summarize current data on the molecular genetic and biochemical mechanisms underlying mitochondrial diseases using Kearns–Sayre syndrome as a model, describe its clinical and diagnostic criteria, and consider promising experimental approaches to targeted therapy.
Methods
Scientific sources from the PubMed database were analyzed using key search terms: Kearns–Sayre syndrome, mitochondrial diseases, chronic progressive external ophthalmoplegia, pigmentary retinopathy, electron transport chain deficiency, and mitochondrial DNA deletion. The primary selection encompassed publications from 2022 to 2026; however, to provide a comprehensive coverage of the topic, selected relevant foundational sources from earlier years were also included.
Results
To review relevant scientific publications was conducted, focusing on the molecular basis of large-scale mtDNA deletions, mechanisms of heteroplasmy, diagnostic algorithms, and novel therapeutic modalities for mitochondrial disorders. It is stated that impairment of the mitochondrial respiratory chain (MRC), specifically complexes I and IV, triggers oxidative stress due to reactive oxygen species accumulation, a metabolic shift toward anaerobic glycolysis with energy depletion, and lactic acidosis, collectively underlying the characteristic clinical triad. Diagnostics relies on a combination of long-range PCR and next-generation sequencing (NGS) of mtDNA from peripheral blood or muscle biopsies to detect low levels of heteroplasmy. Symptomatic management remains the primary approach, however, experimental mitochondrial genome-editing methods show promise for selectively reducing mutant mtDNA levels and restoring MRC functional activity and oxidative phosphorylation.
Conclusions
Mitochondrial diseases are severe multisystem disorders for which timely molecular diagnostics, multidisciplinary surveillance, and the further development of targeted mitochondrial DNA editing technologies are of paramount importance. Keywords: chronic progressive external ophthalmoplegia, deficiency of the electron transport chain, Kearns-Sayre syndrome, mitochondrial diseases, pigmentary retinopathy
Zitieren
APA
Syrvatka, R., Bazaliuk, L., Bilous, V., Pechak, O., & Yanitska, L. (2026). Kearns–Sayre syndrome and large-scale mitochondrial DNA deletion disorders. The Ukrainian Biochemical Journal, 98(5), 5-16. https://doi.org/10.15407/ubj98.05.005
Vancouver
Syrvatka R, Bazaliuk L, Bilous V, Pechak O, Yanitska L. Kearns–Sayre syndrome and large-scale mitochondrial DNA deletion disorders. The Ukrainian Biochemical Journal. 2026;98(5):5-16. doi:10.15407/ubj98.05.005
BibTeX
@article{Syrvatka2026,
author = {Syrvatka, R. and Bazaliuk, L. and Bilous, V. and Pechak, O. and Yanitska, L.},
title = {Kearns–Sayre syndrome and large-scale mitochondrial DNA deletion disorders},
journal = {The Ukrainian Biochemical Journal},
year = {2026},
volume = {98},
number = {5},
pages = {5--16},
doi = {10.15407/ubj98.05.005}
}
EUVIMED